Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-011964
Filing Date
2017-11-14
Accepted
2017-11-14 10:07:36
Documents
36
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0917_ophthalixinc.htm 10-Q 363373
2 CERTIFICATION f10q0917ex31-1_ophthalix.htm EX-31.1 11220
3 CERTIFICATION f10q0917ex31-2_ophthalix.htm EX-31.2 11302
4 CERTIFICATION f10q0917ex32-1_ophthalix.htm EX-32.1 5037
5 CERTIFICATION f10q0917ex32-2_ophthalix.htm EX-32.2 5181
  Complete submission text file 0001213900-17-011964.txt   1849091

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE opli-20170930.xml EX-101.INS 312402
7 XBRL SCHEMA FILE opli-20170930.xsd EX-101.SCH 18788
8 XBRL CALCULATION FILE opli-20170930_cal.xml EX-101.CAL 18138
9 XBRL DEFINITION FILE opli-20170930_def.xml EX-101.DEF 69196
10 XBRL LABEL FILE opli-20170930_lab.xml EX-101.LAB 199739
11 XBRL PRESENTATION FILE opli-20170930_pre.xml EX-101.PRE 124110
Mailing Address 10 BAREKET STREET PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET PETACH TIKVA L3 4951778 972 3 9241114
OphthaliX, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52545 | Film No.: 171198952
SIC: 2834 Pharmaceutical Preparations